Andrew Briggs

Active 1994–2025

147
Papers
39,567
Citations
93
h-index
144
i10-index

Citations

Citations per year for Andrew Briggs1928: 1 citations1977: 1 citations1987: 1 citations1993: 1 citations1995: 3 citations1996: 3 citations1997: 7 citations1998: 17 citations1999: 22 citations2000: 36 citations2001: 40 citations2002: 56 citations2003: 71 citations2004: 114 citations2005: 128 citations2006: 147 citations2007: 107 citations2008: 118 citations2009: 142 citations2010: 131 citations2011: 141 citations2012: 173 citations2013: 183 citations2014: 192 citations2015: 228 citations2016: 218 citations2017: 223 citations2018: 230 citations2019: 1,057 citations2020: 1,178 citations2021: 998 citations2022: 793 citations2023: 558 citations2024: 963 citations2025: 348 citations2026: 13 citations1929–1976: no citations, so these years are not shown1978–1986: no citations, so these years are not shown1988–1992: no citations, so these years are not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited Kingdom: 2,546 citing papers, 16.8% of this breakdownUnited States: 2,480 citing papers, 16.3% of this breakdownAustralia: 865 citing papers, 5.7% of this breakdownCanada: 816 citing papers, 5.4% of this breakdownNetherlands: 797 citing papers, 5.2% of this breakdownGermany: 642 citing papers, 4.2% of this breakdownChina: 497 citing papers, 3.3% of this breakdownSpain: 453 citing papers, 3% of this breakdownItaly: 451 citing papers, 3% of this breakdownFrance: 439 citing papers, 2.9% of this breakdownSwitzerland: 402 citing papers, 2.6% of this breakdownSweden: 330 citing papers, 2.2% of this breakdown
0%16.8%Other 29.4%

Fields

  • Medicine67.5%
  • Economics, Econometrics and Finance9.5%
  • Health Professions5.1%
  • Biochemistry, Genetics and Molecular Biology3.2%
  • Psychology3.1%
  • Computer Science1.6%
  • Other10%

Topics

  • Health Systems, Economic Evaluations, Quality of Life5.2%
  • Asthma and respiratory diseases1.4%
  • Healthcare cost, quality, practices1.1%
  • Long-Term Effects of COVID-191%
  • Diabetes Treatment and Management1%
  • Acute Myocardial Infarction Research0.9%
  • Other89.4%

Coauthors

All papers

Open in search
  1. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force

    Authors: , , , , , , , , , , , , , , - Value in Health 2022 cited by 830

  2. Oral versus Intravenous Antibiotics for Bone and Joint Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Woodhouse, Samantha Stafford, R.A. Seaton, Claire Vallance, Carolyn Hemsley, Karen Bisnauthsing, Jonathan Sandoe, Ila Aggarwal, Simon Ellis, Deborah Bunn, Rebecca Sutherland, Gavin Barlow, Cushla Cooper, Claudia Geue, Nicola McMeekin, Andrew Briggs, Parham Sendi, Elham Khatamzas, Tri Wangrangsimakul, T.H. Nicholas Wong, Lucinda Barrett, Abtin Alvand, ChristopherW. Old, Jennifer Bostock, John R. Paul, Graham Cooke, Guy Thwaites, Philip Bejon, Matthew Scarborough - New England Journal of Medicine 2019 cited by 900

  3. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Davies, Anthony De Soyza, J R Geddes, William Greenhalf, Neil Greening, Liam G. Heaney, Simon Heller, Luke Howard, Joseph Jacob, Gísli Jenkins, Janet M. Lord, William D‐C Man, Gerry P McCann, Stefan Neubauer, Peter Openshaw, Joanna C. Porter, Matthew Rowland, J. T. Scott, Malcolm G. Semple, Sally Singh, David Thomas, Mark Toshner, Keir Lewis, Ryan S. Thwaites, Andrew Briggs, Annemarie B Docherty, S Kerr, Nazir Lone, Jennifer K Quint, Aziz Sheikh, Mathew Thorpe, Bang Zheng, James D. Chalmers, Ling‐Pei Ho, Alex Horsley, Michael Marks, K Poinasamy, Betty Raman, Ewen M. Harrison, Louise V. Wain, Christopher E. Brightling, Kathryn M. Abel, Huzaifa Adamali, Davies Adeloye, O Adeyemi, R Adrego, L A Aguilar Jimenez, Shazaad Ahmad, Nafees Haider, Rizwan Ahmed, N Ahwireng, Mark Ainsworth, B Al-Sheklly, A Alamoudi, Mohammad Ali, M Aljaroof, AM All, Louise Allan, R Allen, L. Allerton, Lynne Allsop, P. Almeida, Doris Altmann, Maria Alvarez Corral, S Amoils, Debra Anderson, Chrystalina A. Antoniades, G Arbane, A. Arias, Chérie Armour and 906 more - The Lancet Respiratory Medicine 2022 cited by 424

  4. Decision Modelling For Health Economic Evaluation

    Authors: , , - 2006 cited by 3,113

  5. Cardiac Troponin T and Troponin I in the General Population

    Authors: , , , , , , , , , , , , , , - Circulation 2019 cited by 327

  6. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

    Authors: , , , , , , , , , - Value in Health 2013 cited by 2,058

  7. Model Parameter Estimation and Uncertainty Analysis

    Authors: , , , , , - Medical Decision Making 2012 cited by 886

  8. Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research

    Authors: , , , , , , , , , , , - PLoS Medicine 2013 cited by 811

  9. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

    Authors: , , , , , , , , , , , , , , - Applied Health Economics and Health Policy 2022 cited by 997

  10. Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes

    Authors: , , , , , , , , , , , , , , - BMJ 2013 cited by 674

  11. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

    Authors: , , , , , , , , , , - BMJ 2013 cited by 1,765

  12. Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

    Authors: , , , - Value in Health 2012 cited by 755

  13. Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

    Authors: , , , , , - Value in Health 2012 cited by 703

  14. Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

    Authors: , , , , , , , - Value in Health 2015 cited by 837

  15. Review of statistical methods for analysing healthcare resources and costs

    Authors: , , , - Health Economics 2010 cited by 773

  16. The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2022 cited by 72

  17. Modeling Good Research Practices—Overview

    Authors: , , , - Medical Decision Making 2012 cited by 511

  18. Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine L. Stables, Christine Cunningham, Christopher Wood, Colm Andrews, David Evans, George Hickman, Helen J Curtis, Henry Drysdale, Iain Dillingham, Jessica Morley, Jon Massey, Linda Nab, Lisa Hopcroft, Louis Fisher, Lucy Bridges, Milan Wiedemann, Nicholas DeVito, Orla Macdonald, Peter Inglesby, Rebecca Smith, Richard Croker, Robin Park, Rose Higgins, Seb Bacon, Simon Davy, Steven Maude, Thomas O’Dwyer, Tom Ward, Victoria Speed, William Hulme, Liam Hart, Pete Stokes, Krishnan Bhaskaran, Ruth Costello, Thomas E. Cowling, Ian Douglas, Rosalind M. Eggo, Stephen Evans, Harriet Forbes, Richard Grieve, Daniel Grint, Emily Herrett, Sinéad Langan, Viyaasan Mahalingasivam, Kathryn E. Mansfield, Rohini Mathur, Helen McDonald, Edward P K Parker, Christopher T. Rentsch, Anna Schultze, Liam Smeeth, John Tazare, Laurie A. Tomlinson, Jemma Walker, Elizabeth M. Williamson, Kevin Wing, Angel Wong, Bang Zheng, Chris Bates, Jonathan Cockburn, John Parry, Frank Hester, Sam Harper, Shaun O’Hanlon, Alex Eavis, Richard Jarvis, Dima Avramov, Paul Griffiths, Aaron Fowles, Nasreen Parkes and 7 more - The Lancet Regional Health - Europe 2024 cited by 96

  19. Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis

    Authors: , , , , , , , , , , , , , , , , , - Cancer Research 2020 cited by 167

  20. An Introduction to Markov Modelling for Economic Evaluation

    Authors: , - PharmacoEconomics 1998 cited by 960

  21. Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions

    Authors: , , - Health Economics 2004 cited by 943

  22. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

    Authors: , , , , , , , , , , - Value in Health 2016 cited by 346

  23. The Future of Fundamental Science Led by Generative Closed-Loop Artificial Intelligence

    Authors: , , , , , , , , , , , , , , , , , , , , , - Frontiers in Artificial Intelligence, Frontiers Artif. Intell. 2023 cited by 23

  24. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation

    Authors: , , - Health Economics 1997 cited by 887